BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

301 related articles for article (PubMed ID: 16311106)

  • 1. Osteosarcoma: basic science and clinical implications.
    Hayden JB; Hoang BH
    Orthop Clin North Am; 2006 Jan; 37(1):1-7. PubMed ID: 16311106
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Osteosarcoma of the head and neck region: lessons learned from a single-institution experience of 50 patients.
    Laskar S; Basu A; Muckaden MA; D'Cruz A; Pai S; Jambhekar N; Tike P; Shrivastava SK
    Head Neck; 2008 Aug; 30(8):1020-6. PubMed ID: 18383528
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Significant recent advances in the treatment of osteogenic sarcoma.
    Cohen IJ
    Isr J Med Sci; 1993 Nov; 29(11):748-53. PubMed ID: 8270413
    [No Abstract]   [Full Text] [Related]  

  • 4. Osteosarcoma with skeletal muscle metastasis.
    Yamada K; Yatabe Y; Sugiura H
    Arch Orthop Trauma Surg; 2008 Jul; 128(7):695-9. PubMed ID: 17622546
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Osteosarcoma in the first decade of life.
    Nagarajan R; Weigel BJ; Thompson RC; Perentesis JP
    Med Pediatr Oncol; 2003 Nov; 41(5):480-3. PubMed ID: 14515397
    [No Abstract]   [Full Text] [Related]  

  • 6. Primary bone osteosarcoma in the pediatric age: state of the art.
    Longhi A; Errani C; De Paolis M; Mercuri M; Bacci G
    Cancer Treat Rev; 2006 Oct; 32(6):423-36. PubMed ID: 16860938
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment algorithm for locally recurrent osteosarcoma based on local disease-free interval and the presence of lung metastasis.
    Nathan SS; Gorlick R; Bukata S; Chou A; Morris CD; Boland PJ; Huvos AG; Meyers PA; Healey JH
    Cancer; 2006 Oct; 107(7):1607-16. PubMed ID: 16933325
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Post operative infection and increased survival in osteosarcoma patients: are they associated?
    Jeys LM; Grimer RJ; Carter SR; Tillman RM; Abudu A
    Ann Surg Oncol; 2007 Oct; 14(10):2887-95. PubMed ID: 17653803
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Osteosarcoma treatment: state of the art.
    Ta HT; Dass CR; Choong PF; Dunstan DE
    Cancer Metastasis Rev; 2009 Jun; 28(1-2):247-63. PubMed ID: 19214708
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Osteosarcoma in patients older than 65 years.
    Longhi A; Errani C; Gonzales-Arabio D; Ferrari C; Mercuri M
    J Clin Oncol; 2008 Nov; 26(33):5368-73. PubMed ID: 18809616
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Prognostic factors for the local recurrence of osteosarcoma in extremities treated with combined therapy].
    Zhang Q; Niu XH; Cai YB; Hao L; Ding Y
    Zhonghua Wai Ke Za Zhi; 2007 Aug; 45(16):1114-7. PubMed ID: 18005614
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased expression of membrane-type matrix metalloproteinase-1 is correlated with poor prognosis in patients with osteosarcoma.
    Uchibori M; Nishida Y; Nagasaka T; Yamada Y; Nakanishi K; Ishiguro N
    Int J Oncol; 2006 Jan; 28(1):33-42. PubMed ID: 16327977
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Sarcomas of the osteogenic series. Evaluation of prognosis criteria].
    Lejeune F; Gompel C
    Ann Anat Pathol (Paris); 1969; 14(2):185-94. PubMed ID: 5259512
    [No Abstract]   [Full Text] [Related]  

  • 14. Pediatric osteosarcoma: a 35-year experience in Slovenia.
    Kuhelj D; Jereb B
    Pediatr Hematol Oncol; 2005 Jun; 22(4):335-43. PubMed ID: 16020121
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Profiling of chemonaive osteosarcoma and paired-normal cells identifies EBF2 as a mediator of osteoprotegerin inhibition to tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis.
    Patiño-García A; Zalacain M; Folio C; Zandueta C; Sierrasesúmaga L; San Julián M; Toledo G; De Las Rivas J; Lecanda F
    Clin Cancer Res; 2009 Aug; 15(16):5082-91. PubMed ID: 19671856
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bone or pleura? Primary pleural osteosarcoma.
    Chandak P; Hunt I; Rawlins R; Lucas S; Treasure T
    J Thorac Cardiovasc Surg; 2007 Feb; 133(2):587-8. PubMed ID: 17258615
    [No Abstract]   [Full Text] [Related]  

  • 17. The treatment of osteogenic sarcoma.
    Brown KL
    Can J Surg; 1986 Jan; 29(1):5-6. PubMed ID: 3455675
    [No Abstract]   [Full Text] [Related]  

  • 18. Tumor necrosis rate adjusted by tumor volume change is a better predictor of survival of localized osteosarcoma patients.
    Kim MS; Lee SY; Cho WH; Song WS; Koh JS; Lee JA; Yoo JY; Jeon DG
    Ann Surg Oncol; 2008 Mar; 15(3):906-14. PubMed ID: 18163171
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genomic alterations and allelic imbalances are strong prognostic predictors in osteosarcoma.
    Smida J; Baumhoer D; Rosemann M; Walch A; Bielack S; Poremba C; Remberger K; Korsching E; Scheurlen W; Dierkes C; Burdach S; Jundt G; Atkinson MJ; Nathrath M
    Clin Cancer Res; 2010 Aug; 16(16):4256-67. PubMed ID: 20610556
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Growth patterns of osteosarcoma predict patient survival.
    Kim MS; Lee SY; Cho WH; Song WS; Koh JS; Lee JA; Yoo JY; Shin DS; Jeon DG
    Arch Orthop Trauma Surg; 2009 Sep; 129(9):1189-96. PubMed ID: 18682966
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.